XRTX

Xortx Therapeutics Inc

• Reuters·1d ago

  XORTX publishes investor presentation outlining gout, kidney disease drug development strategy

• Benzinga·2d ago

  12 Health Care Stocks Moving In Thursday's Intraday Session

• TipRanks·04/01 19:59

  XORTX Therapeutics Secures Exchange Approvals for 1-for-5 Share Consolidation Effective April 6

• TipRanks·04/01 17:05

  Xortx Therapeutics to effect 5-for-1 share consolidation on April 6

• Benzinga·04/01 17:02

  XORTX Therapeutics Announces 1-For-5 Share Consolidation, Effective April 6, 2026

• Reuters·04/01 17:00

  XORTX THERAPEUTICS INC - TO CONSOLIDATE SHARES 1-FOR-5 EFFECTIVE APRIL 6, 2026

• Reuters·04/01 17:00

  XORTX to consolidate shares 1-for-5 effective April 6

• Benzinga·03/27 17:05

  12 Health Care Stocks Moving In Friday's Intraday Session

• TipRanks·03/26 22:39

  XORTX Shareholders Approve Governance Measures and Share Consolidation at Annual Meeting

• Reuters·03/26 22:02

  XORTX Therapeutics held its annual and special meeting of shareholders; 2.4 million shares were represented, about 35% of outstanding shares

• TipRanks·03/26 21:16

  XORTX Delays Effective Date of One-for-Five Share Consolidation

• Benzinga·03/26 20:42

  XORTX Therapeutics Delays 1-for-5 Share Consolidation To April 6, Pending Approvals

• Reuters·03/26 20:37

  XORTX Therapeutics delays 1-for-5 share consolidation effective date to April 6, 2026; consolidation shifts from March 27, 2026

• Reuters·03/26 20:33

  XORTX THERAPEUTICS INC - DELAYS SHARE CONSOLIDATION TO APRIL 6, 2026

• TipRanks·03/26 02:17

  XORTX Consolidates Shares in Bid to Maintain Nasdaq Listing